المؤلفون: Cornelis B. Lambalk, Theodora C. van Tilborg, Ouijdane Hamdine, Helen L. Torrance, Frank J.M. Broekmans, Simone C Oudshoorn, Marinus J.C. Eijkemans, Eef G.W.M. Lentjes

المساهمون: Obstetrics and gynaecology, ACS - Atherosclerosis & ischemic syndromes, Amsterdam Reproduction & Development (AR&D)

المصدر: Oudshoorn, S C, Van Tilborg, T C, Hamdine, O, Torrance, H L, Eijkemans, M J C, Lentjes, E G W M, Lambalk, C B & Broekmans, F J M 2017, ' Ovarian response to controlled ovarian hyperstimulation : What does serum FSH say? ', Human Reproduction, vol. 32, no. 8, pp. 1701-1709 . https://doi.org/10.1093/humrep/dex222
Human Reproduction, 32(8), 1701. Oxford University Press
Human Reproduction, 32(8), 1701-1709. Oxford University Press

مصطلحات موضوعية: Adult, Anti-Mullerian Hormone, endocrine system, medicine.medical_specialty, Serum fsh, Alpha (ethology), Oocyte Retrieval, 030209 endocrinology & metabolism, Controlled ovarian hyperstimulation, controlled ovarian stimulation, recombinant FSH, Chorionic Gonadotropin, law.invention, Cohort Studies, 03 medical and health sciences, Basal (phylogenetics), Young Adult, 0302 clinical medicine, Randomized controlled trial, Obstetrics and gynaecology, Ovulation Induction, law, Pregnancy, Internal medicine, Obstetrics and Gynaecology, Journal Article, Medicine, Humans, ovarian response, serum FSH level, 030219 obstetrics & reproductive medicine, business.industry, IVF/ICSI, Rehabilitation, Obstetrics and Gynecology, Endocrinology, Reproductive Medicine, Female, Follicle Stimulating Hormone, business, hormones, hormone substitutes, and hormone antagonists, Cohort study, Hormone

وصف الملف: image/pdf

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::aae262ddd1dcf910dffc4937ae937e63
https://pubmed.ncbi.nlm.nih.gov/28854580

المؤلفون: Ouijdane, Hamdine, Frank J, Broekmans, Marinus J C, Eijkemans, Cornelis B, Lambalk, Bart C J M, Fauser, Joop S E, Laven, Nick S, Macklon

المساهمون: Public Health, Obstetrics & Gynecology, Obstetrics and gynaecology, ICaR - Ischemia and repair

المصدر: Hamdine, O, Broekmans, F J, Eijkemans, M J C, Lambalk, C B, Fauser, B C J M, Laven, J S E & Macklon, N S 2013, ' Early initiation of gonadotropin-releasing hormone antagonist treatment results in a more stable endocrine milieu during the mid-and late-follicular phases: a randomized controlled trial comparing gonadotropin-releasing hormone antagonist initiation on cycle day 2 or 6 ', Fertility and Sterility, vol. 100, no. 3, pp. 867-874 . https://doi.org/10.1016/j.fertnstert.2013.05.031
Fertility & Sterility, 100(3), 867-874. Elsevier Inc.
Fertility and Sterility, 100(3), 867-874. Elsevier Inc.

مصطلحات موضوعية: Adult, Male, medicine.medical_specialty, endocrine system, Time Factors, medicine.drug_class, medicine.medical_treatment, Endocrine System, Drug Administration Schedule, Intracytoplasmic sperm injection, Gonadotropin-releasing hormone antagonist, Human chorionic gonadotropin, law.invention, Gonadotropin-Releasing Hormone, Hormone Antagonists, Ovulation Induction, Randomized controlled trial, Pregnancy, law, Internal medicine, Follicular phase, Humans, Endocrine system, Medicine, Sperm Injections, Intracytoplasmic, Menstrual Cycle, In vitro fertilisation, business.industry, Obstetrics and Gynecology, Fertility Agents, Female, Treatment Outcome, Endocrinology, Follicular Phase, Reproductive Medicine, Case-Control Studies, Female, business, Luteinizing hormone

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::61bff9eee5c3b7785d4dd41389480c88
https://hdl.handle.net/1765/41069